Clinical trials

At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.

Search for clinical trials by location and speciality

15 May, 2019

Connective Tissue Disorders

DEPART

This study will assess patients with Dupuytren’s Disease in two settings: those who have early stages of the disease, and those who have progressive flexion contractures. It is the first trial of its kind and aims to assess safety and efficacy in the use of radiotherapy in both settings.

Location: Newcastle


15 May, 2019

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Location: Newcastle , Perth, Brisbane, Bundaberg


15 May, 2019

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Location: Melbourne , Frankston


15 May, 2019

Brain Cancer

GBM001

The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.

Location: Newcastle


15 May, 2019

Early Breast Cancer

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Location: Newcastle , Perth


15 May, 2019

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Location: Newcastle , Brisbane, Frankston, Melbourne


To evaluate a new valve in patients with severe mitral regurgitation

Location: Adelaide, Brisbane, Melbourne, Perth


15 May, 2019

Heart Failure Device

COAST

To evaluate a new heart failure sensing device in patients with heart failure

Location: Brisbane


24 April, 2019

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Location: Melbourne, Brisbane


24 April, 2019

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Location: Brisbane, Perth


To evaluate a new valve in patients with severe mitral regurgitation.

Location: Adelaide, Brisbane, Melbourne, Perth


23 April, 2019

High Cholesterol

CLEAR

To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.

Location: Adelaide, Brisbane, Perth, Bundaberg

Clinical Trials

At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.

Connective Tissue Disorders

DEPART

This study will assess patients with Dupuytren’s Disease in two settings: those who have early stages of the disease, and those who have progressive flexion contractures. It is the first trial of its kind and aims to assess safety and efficacy in the use of radiotherapy in both settings.

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Mater Hospital, Sydney (Oncology)

The Mater Hospital, 25 Rocklands road, North Sydney, NSW

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Wembley

24 Salvado Road, Wembley WA, Australia

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Joondalup – Shenton House (Oncology)

Shenton House, Level 3, 57 Shenton Avenue, Joondalup, WA 6027

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Wesley Medical Centre (Oncology)

The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066

Skin Registry

NDROR

To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions

Bundaberg (Oncology)

Bundaberg, Mater Hospital (Oncology), 313 Bourbong Street, Bundaberg, QLD, 4670

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Ringwood (Oncology)

Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Frankston

Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Epping Medical Centre

Epping Medical Centre, Ground Floor, 230 Cooper Street, Epping, VIC, 3076

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

Footscray

Western Private Hospital, 1 Marion Street, Footscray, VIC 3011

Prostate Cancer

IMPPORT

The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.

St Vincent's Melbourne

St Vincent's Hospital, Basement Level, Building C, 41 Victoria Parade, Fitzroy, VIC, 3065

Brain Cancer

GBM001

The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Early Breast Cancer

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Early Breast Cancer

POSNOC

To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.

Fiona Stanley Hospital

Discovery Way Murdoch University, Murdoch WA 6150, Australia

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Newcastle

Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Wesley Medical Centre (Oncology)

The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Frankston

Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199

Early Breast Cancer

EXPERT

A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence

Ringwood (Oncology)

Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

St Andrew's Medical Centre

St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Leabrook

284 Kensington Road, Leabrook, SA 5068

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Doncaster East

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Heidelberg

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Perth Mount (Cardiology)

Suite 3, 140 Mounts Bay Road, Perth, WA 6000

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

Heart Failure Device

COAST

To evaluate a new heart failure sensing device in patients with heart failure

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Berwick (Cardiology)

Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Doncaster East

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Mater Brisbane

Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Joondalup Health Campus

Suite 103, Specialist Medical Centre West, Grand Blvd & Shenton Ave, Joondalup, WA, 6027

Heart Failure due to mitral valve regurgitation

MAVERIC

To evaluate a new valve in patients with severe mitral regurgitation.

St Andrew's Medical Centre

St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000

Heart Failure due to mitral valve regurgitation

MAVERIC

To evaluate a new valve in patients with severe mitral regurgitation.

Leabrook

284 Kensington Road, Leabrook, SA 5068

Heart Failure due to mitral valve regurgitation

MAVERIC

To evaluate a new valve in patients with severe mitral regurgitation.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure due to mitral valve regurgitation

MAVERIC

To evaluate a new valve in patients with severe mitral regurgitation.

Doncaster East

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Heart Failure due to mitral valve regurgitation

MAVERIC

To evaluate a new valve in patients with severe mitral regurgitation.

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

High Cholesterol

CLEAR

To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.

Leabrook

284 Kensington Road, Leabrook, SA 5068

High Cholesterol

CLEAR

To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

High Cholesterol

CLEAR

To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.

Joondalup – Shenton House (Cardiology)

Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027

High Cholesterol

CLEAR

To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

High Cholesterol

CLEAR

To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.

Friendly Society Private Hospital (FSPH) Bundaberg

Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670